(0.19%) 5 141.00 points
(0.19%) 38 514 points
(0.27%) 17 894 points
(-0.85%) $83.14
(1.82%) $1.958
(0.03%) $2 347.90
(0.17%) $27.58
(0.58%) $927.45
(-0.20%) $0.933
(-0.20%) $11.00
(-0.28%) $0.798
(1.08%) $92.86
Live Chart Being Loaded With Signals
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 2.40M |
Vidutinė apimtis | 22.53M |
Rinkos kapitalizacija | 16.37M |
EPS | £0 ( 2023-09-11 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.510 |
ATR14 | £0.0140 (2.72%) |
Tūris Koreliacija
Yourgene Health PLC Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Yourgene Health PLC Koreliacija - Valiuta/Žaliavos
Yourgene Health PLC Finansinės ataskaitos
Annual | 2022 |
Pajamos: | £37.56M |
Bruto pelnas: | £21.37M (56.88 %) |
EPS: | £-0.00260 |
FY | 2022 |
Pajamos: | £37.56M |
Bruto pelnas: | £21.37M (56.88 %) |
EPS: | £-0.00260 |
FY | 2021 |
Pajamos: | £18.29M |
Bruto pelnas: | £11.38M (62.20 %) |
EPS: | £-0.0307 |
FY | 2020 |
Pajamos: | £16.61M |
Bruto pelnas: | £10.22M (61.55 %) |
EPS: | £-0.00400 |
Financial Reports:
No articles found.
Yourgene Health PLC
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.